{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/abbvie-submits-regulatory-application-to-fda-for-skyrizi-risankizumab-rzaa-subcutaneous-induction-for-adults-with-moderately-to-severely-active-crohns-disease-302753553.html", "message": "News view counter 682487 successfully enlarged"}